Literature DB >> 25248030

Longitudinal costs of caring for people with Alzheimer's disease.

Paddy Gillespie1, Eamon O'Shea1, John Cullinan1, Jacqui Buchanan2, Joel Bobula2, Loretto Lacey2, Damien Gallagher3, Aine Ni Mhaolain3, Brian Lawlor3.   

Abstract

BACKGROUND: There has been an increasing interest in the relationship between severity of disease and costs in the care of people with dementia. Much of the current evidence is based on cross-sectional data, suggesting the need to examine trends over time for this important and growing cohort of the population.
METHODS: This paper estimates resource use and costs of care based on longitudinal data for 72 people with dementia in Ireland. Data were collected from the Enhancing Care in Alzheimer's Disease (ECAD) study at two time points: baseline and follow-up, two years later. Patients' dependence on others was measured using the Dependence Scale (DS), while patient function was measured using the Disability Assessment for Dementia (DAD) scale. Univariate and multivariate analysis were used to explore the effects of a range of variables on formal and informal care costs.
RESULTS: Total costs of formal and informal care over six months rose from €9,266 (Standard Deviation (SD): 12,947) per patient at baseline to €21,266 (SD: 26,883) at follow-up, two years later. This constituted a statistically significant (p = 0.0014) increase in costs over time, driven primarily by an increase in estimated informal care costs. In the multivariate analysis, a one-point increase in the DS score, that is a one-unit increase in patient's dependence on others, was associated with a 19% increase in total costs (p = 0.0610).
CONCLUSIONS: Higher levels of dependence in people with Alzheimer's disease are significantly associated with increased costs of informal care as the disease progresses. Formal care services did not respond to increased dependence in people with dementia, leaving it to families to fill the caring gap, mainly through increased supervision with the progress of disease.

Entities:  

Keywords:  function

Mesh:

Year:  2014        PMID: 25248030     DOI: 10.1017/S1041610214002063

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  6 in total

1.  Differences in cognitive performance between informal caregivers and non-caregivers.

Authors:  Francesca Falzarano; Karen L Siedlecki
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2020-04-09

2.  Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample.

Authors:  May A Beydoun; Alyssa A Gamaldo; Hind A Beydoun; Danielle Shaked; Alan B Zonderman; Shaker M Eid
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Alzheimer's Disease Assessments Optimized for Diagnostic Accuracy and Administration Time.

Authors:  Niamh Mccombe; Xuemei Ding; Girijesh Prasad; Paddy Gillespie; David P Finn; Stephen Todd; Paula L Mcclean; Kongfatt Wong-Lin
Journal:  IEEE J Transl Eng Health Med       Date:  2022-04-05

4.  Patterns of health service use in community living older adults with dementia and comorbid conditions: a population-based retrospective cohort study in Ontario, Canada.

Authors:  Lauren E Griffith; Andrea Gruneir; Kathryn Fisher; Dilzayn Panjwani; Sima Gandhi; Li Sheng; Amiram Gafni; Christopher Patterson; Maureen Markle-Reid; Jenny Ploeg
Journal:  BMC Geriatr       Date:  2016-10-26       Impact factor: 3.921

Review 5.  Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders.

Authors:  Youssef H El-Hayek; Ryan E Wiley; Charles P Khoury; Ritesh P Daya; Clive Ballard; Alison R Evans; Michael Karran; José Luis Molinuevo; Matthew Norton; Alireza Atri
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 6.  Utility of the Dependence Scale in dementia: validity, meaningfulness, and health economic considerations.

Authors:  Carolyn W Zhu; Bote Gosse Bruinsma; Yaakov Stern
Journal:  Alzheimers Res Ther       Date:  2018-08-13       Impact factor: 6.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.